InvestorsHub Logo
Followers 2
Posts 71
Boards Moderated 0
Alias Born 04/01/2021

Re: None

Tuesday, 02/28/2023 10:05:24 PM

Tuesday, February 28, 2023 10:05:24 PM

Post# of 233152
lronlimab is at least 8 YEARS AWAY from any approval.
and in that time frame, competition grows and grows.
the scientific advances happening are mind blowing and by the time cytodyn completes a phase 3 for anything, leronlimab will likely be just an "also ran".

the central flaw in CYDY LOLngs is that they have NO IDEA regarding COMPETITION.
you have to be better than the rest to have a shot at decent revs
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News